And here's one more: https://www.clinicaltrials
Post# of 148173
https://www.clinicaltrialsarena.com/news/fda-...l/?cf-view
Toward the bottom of this writing it says:
Quote:
Leronlimab is an experimental humanised immunoglobulin G4 monoclonal antibody that targets C-C chemokine receptor type 5 (CCR5). CytoDyn is also evaluating leronlimab as a treatment for Covid-19, glioblastoma multiforme (GBM), and non-alcoholic steatohepatitis (NASH).
Not sure where Clinical Trials Arena got this info but it's likely incorrect in bringing up covid treatment.
I went through CytoDyn's website and nowhere did I see Covid as something being pursued now/anymore ....
Meanwhile the short video regarding cancer is wonderful:
https://www.cytodyn.com/
Does anyone know how long this video's been on the site?